Thoughts?
Right. And then they will show up on this site and whine and cry like the babies that they are!They’re going to hire over 100 recent college graduates pay them $2 and then complain about why their sales numbers are atrocious.
Thoughts?
Is JM still leading on the remaining reps with another potential drug candidate? Like “ Omaha “ or “ Arctic “. The remaining reps should wake up by now. The leadership doesn’t have the tools or manpower for another launch or co-promote.
They secured a co-promote in an exciting disease state, will be great for the resume!
Training starts next week
Unless this is a giant,pointless game of pretend, yes we are sure.you sure about that?
Unless this is a giant,pointless game of pretend, yes we are sure.
you sure about that?
just curious as to how many business development projects you have worked and then what you could share about your successes?
That does not answer the question about your experience launching products to be able to judge. You’re just another bitter person who was managed out.JM and the upper management is not experience enough to handle another drug launch. Pharmaceuticals has changed since Livalo. They do not have enough man power to launch another drug.
That does not answer the question about your experience launching products to be able to judge. You’re just another bitter person who was managed out.
That does not answer the question about your experience launching products to be able to judge. You’re just another bitter person who was managed out.
That does not answer the question about your experience launching products to be able to judge. You’re just another bitter person who was managed out.
No one was managed out. They left or were forced out if they didn’t have SEG TRXs. Now KPA has no product. They have been searching for almost 2 years now. My point was it’s not easy to launch a drug look at SEG. Manage care and for formulary coverage is incredibly difficult. Look how SEG was ended due to that reason! Kowa marketing and managed care team is nonexistent and it shows. Launching another product there is no confidence. They put the reps through 2 years of hell and paid them the lowest in the industry then ended everything because they do NOT have the man power to get on formularies which is how a medication is paid and reimburse. JM and the upper management need to learn that. Instead of saying “it works”.
No one was managed out. They left or were forced out if they didn’t have SEG TRXs. Now KPA has no product. They have been searching for almost 2 years now. My point was it’s not easy to launch a drug look at SEG. Manage care and for formulary coverage is incredibly difficult. Look how SEG was ended due to that reason! Kowa marketing and managed care team is nonexistent and it shows. Launching another product there is no confidence. They put the reps through 2 years of hell and paid them the lowest in the industry then ended everything because they do NOT have the man power to get on formularies which is how a medication is paid and reimburse. JM and the upper management need to learn that. Instead of saying “it works”.
Forced out and managed out are two sides of the same coin. Why split hairs? As far as SEG goes, that drug was never going to get on formularies. What other drug do you know that is a combination of two ancient drugs that is reimbursed by insurance at an expensive rate with nothing special about it?
Maybe on premium insurance it gets reimbursed but not even on plans such as our Blue Cross Blue Shield could they have hoped for reimbursement. Even the reps knew this. I am not sure why anybody would think it would be different. If Livalo was being launched again tomorrow, and there were still a few other branded statins hanging around, you better believe it would be on formularies. That is a completely different situation. Whatever our new product is, somebody else’s managed care team has taken care of the formularies. You don’t need to cry about it over and over, for the love of God.
They have something coming but there is a PDUFA date established for July 7th, 2024 for the new indication
They have something coming but there is a PDUFA date established for July 7th, 2024 for the new indication